Get all your news in one place.
100's of premium titles.
One app.
Start reading
MarketBeat
MarketBeat
Gabriel Osorio-Mazilli

Will Hims & Hers Fall Along With Novo Nordisk?

One of the most widely watched names in the healthcare sector is Hims & Hers Health Inc. (NYSE: HIMS), not only due to its rampant price action over the past six months, but also because of its underlying growth story, which almost makes it feel like a miracle in the making. The reason behind its popularity lies in the fact that it combines the safety of health services along with the sort of growth reserved for the technology space of the market.

However, most investors have associated Hims & Hers stock with the world of weight loss lately, in a sort of Ozempic boom. Given the company's recent entry into this space, this association has some justification.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.